BioRestorative Therapies earnings beat by $0.01, revenue fell short of estimates
Entity Intersection Graph
No entity connections available yet for this article.
Original Source
try{ var _=i o; . if(!_||_&&typeof _==="object"&&_.expiry Trump Mulls deployment of Marines to Iran, Houthis strike Israel as war continues Expert says the upcoming week will be a pivotal moment in the Iran war. Here’s why Leading broker sees gold falling to $3,700 as a real possibility U.S. tech pullback mirrors late stages of dotcom era, strategists say (South Africa Philippines Nigeria) BioRestorative Therapies earnings beat by $0.01, revenue fell short of estimates By Earnings Published 03/29/2026, 12:23 AM BioRestorative Therapies earnings beat by $0.01, revenue fell short of estimates 0 BRTX 0.34% Investing.com - BioRestorative Therapies (NASDAQ: BRTX ) reported first quarter EPS of $-0.330, $0.01 better than the analyst estimate of $-0.340. Revenue for the quarter came in at $19.6K versus the consensus estimate of $520K. BioRestorative Therapies’s stock price closed at $0.30. It is down -74.520% in the last 3 months and down -83.590% in the last 12 months. BioRestorative Therapies saw positive EPS revisions and negative EPS revisions in the last 90 days. See BioRestorative Therapies’s stock price’s past reactions to earnings here . According to InvestingPro , BioRestorative Therapies’s Financial Health score is " weak performance ". Check out BioRestorative Therapies’s recent earnings performance , and BioRestorative Therapies’s financials here . Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar
Read full article at source